/
DH
$0.72+$0.06 (+8.80%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$69.6M
106M shares
52-week range
$0.62 – $4.70
2% from low
Sector
SERVICES-PREPACKAGED SOFTWARE
Exchange
NASDAQ
CS
Borrow rate
0.95%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-42.57
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $85.5M | $118.3M | $166.2M | $222.7M | $251.4M | $252.2M | $241.5M |
| Cost of revenue | $43.0M | $30.5M | $40.7M | $42.6M | $47.5M | $54.7M | $58.2M |
| Gross profit | $42.5M | $87.8M | $125.5M | $180.0M | $203.9M | $197.5M | $183.3M |
| Gross margin | 49.7% | 74.2% | 75.5% | 80.9% | 81.1% | 78.3% | 75.9% |
| R&D | $7.4M | $11.1M | $18.6M | $34.9M | $42.4M | $36.5M | $34.8M |
| Operating income | −$2.2M | −$15.9M | −$27.3M | −$44.0M | −$329.8M | −$710.8M | −$20.6M |
| EBITDA | $15.5M | $43.5M | $23.1M | $26.2M | −$241.2M | −$567.2M | −$162.2M |
| Net income | −$36.4M | −$52.6M | −$51.9M | −$7.2M | −$202.4M | −$413.1M | −$138.9M |
| Net margin | -42.6% | -44.5% | -31.2% | -3.2% | -80.5% | -163.8% | -57.5% |
| EPS (diluted) | -0.24 | -0.53 | -0.19 | -0.07 | -1.79 | -3.54 | -1.30 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $224M | $0.18 | $0.17–$0.21 | 6 |
| 2027 | $225M | $0.19 | $0.09–$0.23 | 6 |
| 2028 | $241M | $0.20 | $0.20–$0.21 | 3 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
Definitive Healthcare Corp. Class A Common Stock
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
www.definitivehc.com- Employees
- 686
- IPO / List date
- Sep 15, 2021
- HQ
- FRAMINGHAM, MA
Held by traders on TradeandTell
No one on the platform currently holds DH.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 511,140 | $628.7K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded DH yet.
